COVID-19对肺与危重症医学专科培训医师在训考试表现的影响:一项全国性研究
该回顾性研究纳入2015年4月至2022年7月全美完成PCCM-ITE的全部PCCM专科培训医师,共评估12,774份考试分数(8,391人),分为疫情前(PP)、第一波疫情(CW1,2020年3月1日至2021年6月30日)和第二波疫情(CW2,2021年7月1日及以后)三个队列。采用线性混合效应模型分析疫情与ITE分数的关系。结果显示,CW1期间FY2和FY3的总分最低二乘均值分别较PP期高2.0%(95%CI 0.4%-3.5%,P=.02)和2.9%(95%CI 1.3%-4.6%,P=.001);FY3的呼吸亚组分数在CW1期间高5.3%(95%CI 1.5%-9.1%,P=.01);FY0的重症医学亚组分数在CW1和CW2期间分别较PP低2.2%(95%CI -4.3%至-0.1%,P=.04)和2.9%(95%CI -4.9%至-0.8%,P=.007)。作者认为疫情对认知表现的影响较小,可能被CW1期间学员自我学习机会增强所缓冲。
要点
- CW1期间FY2和FY3的ITE总分最低二乘均值分别较PP期高2.0%(95%CI 0.4%-3.5%,P=.02)和2.9%(95%CI 1.3%-4.6%,P=.001)。
- CW1期间FY3的呼吸亚组分数较PP期高5.3%(95%CI 1.5%-9.1%,P=.01),其他培训年级在第一波或第二波疫情期无显著差异。
- FY1、FY2和FY3的重症医学亚组分数在各时期相似;FY0的重症医学亚组分数在CW1和CW2期间分别较PP期低2.2%(95%CI -4.3%至-0.1%,P=.04)和2.9%(95%CI -4.9%至-0.8%,P=.007)。
- FY0和FY1的总分在CW1期间与PP期相似,未见下降。
- 作者认为疫情对认知表现的影响较小,可能被CW1期间学员自我学习机会增强所缓冲。
适用人群与场景
- 美国所有在2015年4月至2022年7月间完成PCCM-ITE的PCCM专科培训医师。
- 按培训年份分为FY0(培训前3个月内参加的考试)和FY1-FY3(培训第1-3年内参加的考试)。
研究设计与关键结果
- 研究类型:回顾性研究,纳入全美PCCM专科培训医师,共评估12,774份PCCM-ITE考试分数(8,391人)。
- 分组:疫情前(PP,2020年3月1日前)、第一波疫情(CW1,2020年3月1日至2021年6月30日)、第二波疫情(CW2,2021年7月1日及以后)。
- 主要终点:CW1期间FY2和FY3的总分最低二乘均值分别较PP期高2.0%(95%CI 0.4%-3.5%,P=.02)和2.9%(95%CI 1.3%-4.6%,P=.001);FY0和FY1的总分与PP期相似。
- 次要终点:CW1期间FY3的呼吸亚组分数较PP期高5.3%(95%CI 1.5%-9.1%,P=.01),其他培训年级在第一波或第二波疫情期无显著差异。
- 次要终点:FY1、FY2和FY3的重症医学亚组分数在各时期相似;FY0的重症医学亚组分数在CW1和CW2期间分别较PP期低2.2%(95%CI -4.3%至-0.1%,P=.04)和2.9%(95%CI -4.9%至-0.8%,P=.007)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为疫情对认知表现的影响较小,可能被CW1期间学员自我学习机会增强所缓冲。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Between 2020 and 2022, the COVID-19 pandemic disrupted health and education. Many training institutions modified trainees' rotations, decreasing outpatient clinics while increasing inpatient and ICU time. Understanding the pandemic's impact on medical trainees' cognitive performance is essential for informing strategies and supporting trainee well-being during crises.
RESEARCH QUESTION: What was the impact of the COVID-19 pandemic on the performance of pulmonary and critical care medicine (PCCM) fellows on the in-training examination (ITE)?
STUDY DESIGN AND METHODS: Retrospective study included all PCCM fellows in the United States who completed the PCCM-ITE between April 2015 and July 2022. Participants were divided into 3 cohorts: a pre-pandemic (PP) (ITE before March 1, 2020), first COVID-19 wave (CW) (March 1, 2020 to June 30, 2021), and second CW cohort (on or after July 1, 2021). We used a linear mixed-effect model to explore the relationship between the pandemic and ITE scores. We designated fellows by fellowship year (FY0 through FY3). A test taken within the first 3 months of fellowship training was designated FY0. A test taken within fellowship years 1-3 was designated F1-FY3.
RESULTS: A total of 12,774 PCCM-ITE examination scores were evaluated for 8,391 individuals. During the first CW, least squares (LS) mean total scores for FY0 and FY1 were similar to those in the PP period. However, FY2 and FY3 demonstrated higher LS mean total scores, with differences of 2.0% (95% CI, 0.4%-3.5%; P = .02) and 2.9% (95% CI, 1.3%-4.6%; P = .001), respectively, compared with the PP period. LS mean pulmonary subsection scores were 5.3% (95% CI, 1.5%-9.1%; P = .01) higher for FY3 trainees during CW1, and no significant differences were observed for other trainee levels during the first CW or second CW. Critical care subsection scores were similar for FY1, FY2, and FY3 trainees across all periods. FY0 trainees had lower critical care scores during the first CW (-2.2%; 95% CI, -4.3% to -0.1%; P = .04) and second CW (-2.9%; 95% CI, -4.9% to -0.8%; P = .007), compared with PP.
INTERPRETATION: In conclusion, our results indicate that pandemic impacts on cognitive performance were minimal, possibly buffered by enhanced self-study opportunities among trainees during CW1.
参考来源
- Alwakeel M, Patrawalla P, Carlin B, et al. Impact of COVID-19 on Pulmonary Critical Care Fellows In-Training Exam Performance: A National Study. Chest. 2025. PMID: 40268241. doi:10.1016/j.chest.2025.04.015
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。